Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Azithromycin Capsules produced by Guangzhou Baiyunshan Pharmaceutical Holdings have passed the evaluation for generic drug consistency.

Recently, Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory"), has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration. Azithromycin capsules have passed the generic drug quality and efficacy consistency evaluation. The announcement stated that the azithromycin capsules of Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory have passed the generic drug consistency evaluation, which is beneficial for enhancing the market competitiveness of this drug.